FREQUENTLY ASKED QUESTIONS
What is the official ID of this bill?
The official print number for this legislation is 118_HR_10444.
Which chamber initiated this legislation?
This legislation was initiated in the House of Representatives.
When did the legislative process begin?
The process officially started on 2024-12-17.
What are the main provisions?
Key points include:
- States will not be able to establish their own prohibitions or restrictions on the sale, distribution, or advertising of alternative tobacco products if these products have federal marketing authorization.
- Federal regulations will take precedence over local rules regarding product standards, premarket review, labeling, and other technical matters.
- The act requires the Food and Drug Administration (FDA) to submit a report on the status of all pending applications for new tobacco products and modified risk tobacco products.
What is the specific legal status?
The current status is Expired.
Where can I read the full text of this legislation?
The full official text is available at:
View full text
Who is the primary sponsor?
The primary sponsor is Rep. Bergman, Jack [R-MI-1].
What is the latest detailed status?
The latest detailed status is: Referred to the House Committee on Energy and Commerce.
Is this summary verified?
Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.
What is the impact of this bill?
We don't know—that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.